May 28, 2026 08:08AM
May 28, 2026 08:00AM
Apr 29, 2026 04:03PM
Oct 7, 2025 08:00AM
Jul 23, 2025 08:00AM
Feb 25, 2025 04:02PM
Oct 28, 2024 07:00AM PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
Oct 8, 2024 08:11AM
Oct 8, 2024 07:30AM
Oct 7, 2024 04:04PM
Oct 7, 2024 04:04PM
Aug 22, 2024 05:36AM
Aug 21, 2024 11:14AM
Aug 21, 2024 07:02AM PROCEPT BioRobotics Corporation (PRCT) Announces FDA Clearance of the HYDROS Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
Aug 21, 2024 07:00AM
May 6, 2024 08:00AM
Apr 23, 2024 08:00AM
Nov 1, 2023 04:02PM
Oct 12, 2023 08:00AM
Oct 12, 2023 08:00AM
Sep 12, 2023 08:00AM PROCEPT BioRobotics Corporation (PRCT) Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
Sep 12, 2023 08:00AM
Aug 22, 2023 08:00AM
Aug 22, 2023 08:00AM
Apr 28, 2023 08:03AM
Apr 28, 2023 08:00AM
Apr 3, 2023 08:10AM
Apr 3, 2023 08:00AM PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates
Apr 3, 2023 08:00AM
Aug 4, 2022 04:03PM
Aug 4, 2022 04:03PM
Feb 14, 2022 04:03PM
Feb 14, 2022 04:03PM
Feb 14, 2022 04:03PM

322,900 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All